1. Home
  2. MDXH vs SHMD Comparison

MDXH vs SHMD Comparison

Compare MDXH & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • SHMD
  • Stock Information
  • Founded
  • MDXH 2003
  • SHMD 1864
  • Country
  • MDXH Belgium
  • SHMD Germany
  • Employees
  • MDXH N/A
  • SHMD N/A
  • Industry
  • MDXH
  • SHMD
  • Sector
  • MDXH
  • SHMD
  • Exchange
  • MDXH Nasdaq
  • SHMD Nasdaq
  • Market Cap
  • MDXH 93.1M
  • SHMD 100.8M
  • IPO Year
  • MDXH 2021
  • SHMD N/A
  • Fundamental
  • Price
  • MDXH $2.37
  • SHMD $3.10
  • Analyst Decision
  • MDXH Strong Buy
  • SHMD
  • Analyst Count
  • MDXH 2
  • SHMD 0
  • Target Price
  • MDXH $7.00
  • SHMD N/A
  • AVG Volume (30 Days)
  • MDXH 162.3K
  • SHMD 55.1K
  • Earning Date
  • MDXH 11-06-2024
  • SHMD 12-24-2024
  • Dividend Yield
  • MDXH N/A
  • SHMD N/A
  • EPS Growth
  • MDXH N/A
  • SHMD 1309.32
  • EPS
  • MDXH N/A
  • SHMD 1.07
  • Revenue
  • MDXH $84,708,000.00
  • SHMD $99,752,404.00
  • Revenue This Year
  • MDXH $27.57
  • SHMD N/A
  • Revenue Next Year
  • MDXH $20.09
  • SHMD N/A
  • P/E Ratio
  • MDXH N/A
  • SHMD $3.05
  • Revenue Growth
  • MDXH 33.01
  • SHMD N/A
  • 52 Week Low
  • MDXH $1.55
  • SHMD $1.98
  • 52 Week High
  • MDXH $4.64
  • SHMD $6.13
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 65.97
  • SHMD N/A
  • Support Level
  • MDXH $2.34
  • SHMD N/A
  • Resistance Level
  • MDXH $2.52
  • SHMD N/A
  • Average True Range (ATR)
  • MDXH 0.14
  • SHMD 0.00
  • MACD
  • MDXH 0.05
  • SHMD 0.00
  • Stochastic Oscillator
  • MDXH 77.61
  • SHMD 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: